These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 25322652)

  • 21. [Pharmacokinetics and metabolism of tofizopam (Grandaxin)].
    Klebovich I; Abermann M
    Acta Pharm Hung; 1993 Mar; 63(2):83-90. PubMed ID: 8100113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological profile of the novel putative anxiolytic agent 1-amino-5-bromouracil.
    Imaizumi M; Miyazaki S; Watanabe Y; Machida H
    Arzneimittelforschung; 1994 Mar; 44(3):285-8. PubMed ID: 7910744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunomodulators levamisole, muramyl dipeptide and adamantylamide dipeptide antagonize the antianxiety effect of diazepam.
    Sulcová A; Gulda O
    Act Nerv Super (Praha); 1989 Jun; 31(2):111-3. PubMed ID: 2572130
    [No Abstract]   [Full Text] [Related]  

  • 24. Dipeptide Tyr-Leu (YL) exhibits anxiolytic-like activity after oral administration via activating serotonin 5-HT1A, dopamine D1 and GABAA receptors in mice.
    Kanegawa N; Suzuki C; Ohinata K
    FEBS Lett; 2010 Feb; 584(3):599-604. PubMed ID: 20005875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetic evaluation of a new prolonged dosage form of afobazole in comparison to commercially available tablets].
    Bochkov PO; Litvin AA; Kolyvanov GB; Zherdev VP; Blynskaia EV; Grushevskaia LN; Illarionov AA
    Eksp Klin Farmakol; 2013; 76(11):33-5. PubMed ID: 24555231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The mechanism of action of benzodiazepine and its consequences for therapy].
    Cugurra F
    Clin Ter; 1992 Apr; 140(4):331-43. PubMed ID: 1350239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New approach in bioavailability study of two formulations of ethyl loflazepate.
    Ba BB; Iliadis A; Durand A; Berger Y; Cano JP
    Arzneimittelforschung; 1988 Oct; 38(10):1486-9. PubMed ID: 2904268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The disposition and pharmacokinetics of alpidem, a new anxiolytic, in the rat.
    Garrigou-Gadenne D; Durand A; Thenot JP; Morselli PL
    Drug Metab Dispos; 1991; 19(3):574-9. PubMed ID: 1680622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and safety of deramciclane during multiple oral dosing.
    Kanerva H; Kilkku O; Helminen A; Rouru J; Scheinin M; Huupponen R; Klebovich I; Drabant S; Urtti A
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):589-97. PubMed ID: 10599951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel β-lactoglobulin-derived peptides, wheylin-1 and -2, having anxiolytic-like activity in mice.
    Yamada A; Mizushige T; Kanamoto R; Ohinata K
    Mol Nutr Food Res; 2014 Feb; 58(2):353-8. PubMed ID: 24039078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neurotensine dipeptide analog dilept decreases the deficiency of prestimulus startle reflex inhibition: a prognostic sign of antipsychotic activity].
    Ostrovskaia RU; Krupina NA; Gudasheva TA; Voronina TA; Seredenin SB
    Eksp Klin Farmakol; 2009; 72(5):3-7. PubMed ID: 19928566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism.
    Anand BS; Katragadda S; Mitra AK
    J Pharmacol Exp Ther; 2004 Nov; 311(2):659-67. PubMed ID: 15226381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of anxiety in rats evaluated in the elevated T-maze: evidence of the relationship between substance P and diazepam.
    Duzzioni M; Calixto AV; Duarte FS; De Lima TC
    Behav Brain Res; 2008 Feb; 187(1):140-5. PubMed ID: 17963853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of anxiolytic effect and withdrawal anxiety in chronic intermittent diazepam treatment in rats.
    Açikmeşe B; Haznedar S; Hatipoğlu I; Enginar N
    Behav Pharmacol; 2012 Apr; 23(2):215-9. PubMed ID: 22327020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacology of anxiolytic agents in the cardio-vascular domain].
    Danion JM
    Arch Mal Coeur Vaiss; 1987 May; 80 Spec No():57-62. PubMed ID: 2889437
    [No Abstract]   [Full Text] [Related]  

  • 36. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between cerebral pharmacokinetics and anxiolytic activity of diazepam and its active metabolites after a single intra-peritoneal administration of diazepam in mice.
    Dailly E; Hascoët M; Colombel MC; Jolliet P; Bourin M
    Hum Psychopharmacol; 2002 Jul; 17(5):239-45. PubMed ID: 12404681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buspirone, a novel nonbenzodiazepine anxiolytic.
    Kastenholz KV; Crismon ML
    Clin Pharm; 1984; 3(6):600-7. PubMed ID: 6150781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Method development studies for repeatedly measuring anxiolytic drug effects in healthy humans.
    Klumpers F; van Gerven JM; Prinssen EP; Niklson I; Roesch F; Riedel WJ; Kenemans JL; Baas JM
    J Psychopharmacol; 2010 May; 24(5):657-66. PubMed ID: 19329545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A critical test of the hippocampal theta model of anxiolytic drug action.
    Yeung M; Treit D; Dickson CT
    Neuropharmacology; 2012 Jan; 62(1):155-60. PubMed ID: 21723303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.